凯普生物：回应条例下应收账款回收及催收措施情况

Core Viewpoint - The revised "Regulations on Ensuring Payment to Small and Medium Enterprises" will take effect on June 1, 2025, mandating timely payments from government agencies, institutions, and large enterprises to SMEs, with a maximum payment period of 60 days [1] Company Summary - As of June 30, 2025, the company's accounts receivable balance is 1,926.199 million, with a bad debt provision of 985.587 million, resulting in a book value of 940.612 million [1] - Accounts receivable related to unconventional testing products and medical testing services from 2020 to 2022 amount to 1,296.857 million, with a book value of 420.665 million [1] - The company emphasizes the importance of accounts receivable recovery, treating it as a top management priority, and has formed a dedicated management team involving finance, business, legal, and market professionals [1] Industry Summary - The government has been intensifying efforts to address the issue of delayed payments from government agencies, institutions, and state-owned enterprises to private enterprises, clarifying responsible departments and enhancing audit supervision [1] - The company is actively engaging with relevant government departments to report on the situation and seek support in coordinating and urging local governments to fulfill their repayment responsibilities [1]